IDEAYA Biosciences, Inc. (IDYA) Form 424B5 — Jun 9, 2026
IDEAYA Biosciences, Inc. (IDYA) is offering 5,555,556 shares of common stock and pre-funded warrants to purchase 5,555,576 shares at a public offering price of $27.00 per share, raising gross proceeds of approximately $300 million. The net proceeds to IDEAYA are estimated at $281.3 million, or $323.6 million if the underwriters exercise their option to purchase an additional 1,666,669 shares. The capital raise supports the continued clinical development and potential commercialization of darovasertib for uveal melanoma, following positive Phase 2/3 trial data presented at ASCO 2026.
Key figures
- Greenshoe
- 1666669
- Net Proceeds
- 281300000
- Gross Proceeds
- 300000008
- Offering Price
- 27
- Shares Offered
- 5555556
- Dilution Per Share
- 13.95
- Shares Outstanding
- 87856154
- Underwriting Discount
- 1.62
- Net Proceeds With Option
- 323600000
- Net Tangible Book Value Per Share
- 10.67
- Shares Outstanding Post Offering
- 93411710
- Adjusted Net Tangible Book Value Per Share
- 13.05
- Lockup Period
- 60 days
- Last Sale Price
- 31.48
- Pre Funded Warrant Price
- 26.9999
- Pre Funded Warrants Offered
- 5555576
- Pre Funded Warrant Exercise Price
- 0.0001
Price after filing
Close on the filing date to close N calendar days later (from $28.07). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.